HOME >> MEDICINE >> NEWS
Trial Begins For First Artificial Liver Device Using Human Cells

Physicians at the University of Chicago Hospitals are beginning clinical testing of the first artificial liver device that uses cells from humans rather than from pigs. The ELAD (Extracorporeal Liver Assist Device), produced by VitaGen Incorporated of La Jolla, California, is designed to serve as a temporary liver for patients with acute liver failure, keeping them alive until their own organ can recover or until a suitable organ becomes available for transplantation.

As the pilot center for the first controlled trial of the device, the University of Chicago is the only hospital in the world currently able to offer this treatment. This study will determine the safety and efficacy of the device.

"Several previous devices containing liver cells from pigs have produced encouraging results," said Michael Millis, M.D., associate professor of surgery and director of the liver transplant program at the University of Chicago Hospitals, "but there has been a good deal of concern about exposing patients to animal cells, which may function slightly differently and could harbor infectious agents. This trial should determine whether a device that incorporates human rather than pig-liver cells can reduce those risks and perhaps function more like a normal human organ."

A second advantage is that this device can be used continuously by changing the cartridges every few hours. The artifical liver devices containing pig cells can be used for no more than six to eight hours each day.

The study will involve patients with fulminant hepatic failure (FHF), a rapidly worsening liver dysfunction that primarily occurs in young, healthy people
'"/>

Contact: John Easton
jeaston@mcis.bsd.uchicago.edu
773-702-6241
University of Chicago Medical Center
5-Apr-1999


Page: 1 2 3

Related medicine news :

1. Trial reveals safer and simpler approach to treating children with cystic fibrosis
2. Trials launched to test treatment of cognitive dysfunction in schizophrenia
3. Randomisation phase of the DIRECT programme (DIabetic REtinopathy Candesartan Trials) completed
4. Trials on hormone therapy and hypertension treatment change practice, medication usage of patients
5. Trial results have dramatically reduced HRT use
6. Release of results of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
7. Trial opens new possibilities for improving survival with a novel heart attack drug
8. Clinical Trials Litigation: Legal & Ethical Issues in Human Subjects Research
9. National Lung Screening Trial
10. New awards, expanded focus for Pediatric AIDS Clinical Trials Group
11. AAPS Workshop to Examine Chemistry and Manufacturing Controls Trials, Emerging Products

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/16/2019)... ... 2019 , ... SilcSkin – silicone anti-wrinkle pad pioneer and creator of the ... for 2019 in the Neck and Decolleté category for the second time. The Decollette ... of the International Congress of Esthetics and Spa. Developed by two-time Emmy award winning ...
(Date:2/14/2019)... ... February 14, 2019 , ... At the 2019 Consumer ... Personal Cardiac Assistant (PCA 500), the only FDA-cleared, hospital quality, 12-lead electrocardiogram (ECG) ... single lead ECGs and identify arrhythmias, including atrial fibrillation or AFib. A 12-lead ...
(Date:2/13/2019)... ... ... CBD Hacker , the definitive guide to the CBD industry, has named ... of rigorous testing of more than 20 products, including third-party potency testing, hands-on evaluations, ... a fast-acting, effective delivery method for CBD. And the fact that it’s a highly ...
(Date:2/13/2019)... ... February 13, 2019 , ... With Valentine’s Day tomorrow and love in ... service, is sharing 7 tips to ensure ‘Safe Sex’: , 1. Talk To ... engage in safe sex. Having clear, open, and honest communication is key so that ...
(Date:2/13/2019)... ... ... Castle announced today that it has raised $9.2M in Series A funding from ... First Round and F-Prime Capital Partners . Angel investors joining the round ... Networks, and Olivier Pomel, CEO at Datadog. This round brings the company’s total funding ...
Breaking Medicine News(10 mins):
(Date:2/14/2019)... ... February 14, 2019 , ... Shady Grove Fertility ... Desireé McCarthy-Keith has been named Medical Director for the Atlanta region. This ... and the local Atlanta community in helping patients overcome infertility. In this role, ...
(Date:2/14/2019)... VIEJO, Calif. (PRWEB) , ... ... ... privately-held spinal device company that focuses on developing and commercializing minimally-invasive, innovative ... Surgical, Inc. , “The Amplify Surgical name better emphasizes our commitment to ...
(Date:2/14/2019)... (PRWEB) , ... February 14, 2019 , ... ... physicians of Asheville Radiology Associates (ARA), in Asheville, North Carolina. , “We ... the many collaborative opportunities available through Strategic Radiology,” said Arl Van Moore Jr, ...
Breaking Medicine Technology:
Cached News: